The data suggest that pathological activation of LNX1 and RhoC contributions to a lissencephaly phenotype may be the consequence of reduced LIS1 protein levels rather than missense-dependent disruption of LNX1-LIS1 specific binding. The gene discussed is PAFAH1B1; the disease is Lissencephaly.